GRK1
Rhodopsin kinase GRK1
Also known as: GPRK1, GRK1_HUMAN, RHOK, RK
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q15835
- Gene
- GRK1
- Ensembl
- ENSG00000185974
- Chromosome
- 13
- Canonical length
- 563 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Principal piece
OverviewNCBI Gene
This gene encodes a member of the guanine nucleotide-binding protein (G protein)-coupled receptor kinase subfamily of the Ser/Thr protein kinase family. The protein phosphorylates rhodopsin and initiates its deactivation. Defects in GRK1 are known to cause Oguchi disease 2 (also known as stationary night blindness Oguchi type-2). [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
563 residues, UniProt reviewed canonical sequence.
>Q15835|GRK1
1 MDFGSLETVV ANSAFIAARG SFDGSSSQPS RDKKYLAKLK LPPLSKCESL RDSLSLEFES
61 VCLEQPIGKK LFQQFLQSAE KHLPALELWK DIEDYDTADN DLQPQKAQTI LAQYLDPQAK
121 LFCSFLDEGI VAKFKEGPVE IQDGLFQPLL QATLAHLGQA PFQEYLGSLY FLRFLQWKWL
181 EAQPMGEDWF LDFRVLGKGG FGEVSACQMK ATGKLYACKK LNKKRLKKRK GYQGAMVEKK
241 ILMKVHSRFI VSLAYAFETK ADLCLVMTIM NGGDIRYHIY NVNEENPGFP EPRALFYTAQ
301 IICGLEHLHQ RRIVYRDLKP ENVLLDNDGN VRISDLGLAV ELLDGQSKTK GYAGTPGFMA
361 PELLQGEEYD FSVDYFALGV TLYEMIAARG PFRARGEKVE NKELKHRIIS EPVKYPDKFS
421 QASKDFCEAL LEKDPEKRLG FRDETCDKLR AHPLFKDLNW RQLEAGMLMP PFIPDSKTVY
481 AKDIQDVGAF STVKGVAFDK TDTEFFQEFA TGNCPIPWQE EMIETGIFGE LNVWRSDGQM
541 PDDMKGISGG SSSSSKSGMC LVSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GRK1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.26
- Highest tissue expression
- 40 nTPM
Expression across tissuesHPA
Tissue
- retina: 40 nTPM
- thyroid gland: 0.8 nTPM
- adipose tissue: 0 nTPM
- adrenal gland: 0 nTPM
- amygdala: 0 nTPM
- appendix: 0 nTPM
Single-cell type
- rod photoreceptor cells: 2.8 nCPM
- cone photoreceptor cells: 2.1 nCPM
- microglia: 0.8 nCPM
- renal collecting duct principal cells: 0.5 nCPM
- late spermatids: 0.4 nCPM
- müller glia: 0.3 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- choroid plexus: 0.4 nTPM
- cerebral cortex: 0.2 nTPM
- hypothalamus: 0.2 nTPM
- medulla oblongata: 0.2 nTPM
- pons: 0.2 nTPM
- amygdala: 0.1 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about GRK1.
Disease | AllUniProt
Conditions GRK1 is implicated in, by any mechanism.
- Night blindness, congenital stationary, Oguchi type 2 (CSNBO2) MIM:613411
Disease | GeneticClinVar
21 pathogenic / likely-pathogenic of 106 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Oguchi disease-2
- Retinal dystrophy
- Congenital stationary night blindness
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.82
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.43
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- G protein-coupled opsin signaling pathway
- protein autophosphorylation
- regulation of G protein-coupled receptor signaling pathway
- regulation of opsin-mediated signaling pathway
- regulation of signal transduction
- visual perception
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- GPCR kinase
- Protein kinase domain
- AGC-kinase, C-terminal
- Serine/threonine-protein kinase, active site
- Protein kinase-like domain superfamily
- RGS domain
- Protein kinase, ATP binding site
- RGS domain superfamily
- RGS, subdomain 2
- Protein kinase domain
- Regulator of G protein signaling domain
- Rhodopsin kinase, catalytic domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of GRK1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GRK1 as an antibody target. Whether an autoantibody or antibody against GRK1 could matter depends on whether native GRK1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GRK1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label GRK1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...